Tirzepatide for PCOS: what the evidence actually supports

What did @shaleenbresha actually say?

Short version: she defended her use of tirzepatide against social judgment, and she did it pretty confidently. The transcript is basically three sentences: she confirmed she's on "that shot," said she plans to stay on it, and told critics to mind their business if they're not paying her bills. There's no medical claim here. No dosing advice. No miracle promises. Just a woman owning her treatment decision.

What's worth noting is what she didn't say. She didn't claim tirzepatide cures PCOS. She didn't say it's easy. The caption even acknowledges "there's no easy way out." That's actually more honest than a lot of GLP-1 content on this platform, which tends to oversell the drugs as effortless transformation tools.

Does the science back this up?

Using tirzepatide for weight management when you have PCOS? There's real evidence building here, even if tirzepatide isn't specifically FDA-approved for PCOS. The underlying mechanism makes biological sense, and researchers are paying attention.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, which means it hits two hormonal pathways that regulate insulin and appetite. PCOS is heavily tied to insulin resistance, which drives androgen overproduction and makes weight loss especially difficult. A 2023 study by Jastreboff et al. in the New England Journal of Medicine (the SURMOUNT-1 trial) showed tirzepatide produced up to 20.9% mean body weight reduction in adults with obesity. Separate research has shown that even modest weight loss of 5-10% can meaningfully improve PCOS symptoms including menstrual regularity and androgen levels. A 2022 review by Joham et al. in Nature Reviews Endocrinology confirmed that weight management remains a first-line intervention for PCOS in people with overweight or obesity.

What did they get wrong (or right)?

Honestly? Not much wrong here, medically speaking. She made no false claims. She didn't tell her 1,200 viewers to go get the shot, didn't mention a dose, didn't imply it's a cure. The caption's framing, "the best tool ever," is enthusiastic but it's clearly personal testimony, not a clinical recommendation.

The one thing worth flagging is not something she said incorrectly, it's something she didn't say at all. Tirzepatide for PCOS is an off-label use. The drug is FDA-approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), but not specifically indicated for PCOS. That doesn't make it inappropriate, physicians prescribe off-label regularly and the physiological rationale is solid. But viewers with PCOS watching this deserve to know that "my doctor put me on this for PCOS" involves a clinical conversation, not just picking up a popular medication.

Also worth being clear: compounded versions of tirzepatide, which circulate widely in telehealth markets, are not the same as FDA-approved brand-name products. Potency and sterility standards differ.

What should you actually know?

If you have PCOS and you're wondering whether a GLP-1 or dual agonist medication might be appropriate for you, that's a legitimate question to bring to a provider. The evidence connecting insulin resistance to PCOS pathophysiology is well-established. A 2021 meta-analysis by Lim et al. in Human Reproduction Update found that GLP-1 receptor agonists improved weight, insulin sensitivity, and androgen markers in women with PCOS compared to placebo.

What this video is not: a clinical recommendation, a dosing guide, or evidence that tirzepatide is right for your specific situation. PCOS presents differently across individuals. Some people have lean PCOS with minimal insulin resistance. Others have significant metabolic dysfunction. Treatment decisions should account for your labs, your history, and your goals, not a TikTok clip.

The creator's attitude, owning her medical decisions without shame, is actually worth something in a space where people with PCOS are frequently told to "just lose weight" without being given real tools or support to do so.